Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Hit, hold or fold? Unilever, GlaxoSmithKline, AstraZeneca shares

| Joe Clark

If I had to buy, sell or hold AstraZeneca, Unilever or GlaxoSmithKline shares, what would I do? Fool UK contributor…

Read more »

Investing Articles

AstraZeneca share price: back to sub-£70 levels. Should I buy now?

| Manika Premsingh

Do not let the AstraZeneca share price fool you. There is still much merit to the stock. Do the positives…

Read more »

Investing Articles

Stock market recovery: I’d invest in these 2 FTSE 100 shares today

| Conor Coyle

FTSE 100 stocks B&M (LSE:BME) and AstraZeneca (LSE:AZN) are two of my top picks for long-term growth following this stock…

Read more »

Investing Articles

Shares to buy now: why I’d consider Lloyds Banking Group alongside this FTSE 100 stock

| Kevin Godbold

Since July, this FTSE 100 company's share price has been trending down. But the decline is at odds with the…

Read more »

Investing Articles

AstraZeneca share price: is this FTSE 100 growth stock now a top ‘dip buy’?

| G A Chester

The AstraZeneca share price has underperformed the FTSE 100 in recent months. G A Chester weighs up its dip-buy credentials.

Read more »

Investing Articles

The AstraZeneca share price: why I’d buy and hold the stock

| Rupert Hargreaves

The AstraZeneca share price has an attractive long-term outlook, thanks to its expansive portfolio of drugs and new treatments.

Read more »

Investing Articles

AstraZeneca: why I’m forgetting the headlines and following the trendlines

| Tej Kohli

AstraZeneca is forging ahead with its portfolio of ‘on trend’ medicines that should prove increasingly profitable.

Read more »

Investing Articles

AstraZeneca shares: 4 reasons I’d buy them now

| Manika Premsingh

The AZN share price has been subdued for the last few months, but Manika Premsingh thinks that’s about to change. 

Read more »

Investing Articles

FTSE 100 shares to buy: AstraZeneca has rediscovered its growth mojo

| Kevin Godbold

Here's why I like the look of AstraZeneca shares today and I think the investment risks are balanced by the…

Read more »

Investing Articles

Top British stocks for February 2021

| The Motley Fool Staff

We asked our freelance writers to share their top British stocks for February, including Lloyds Banking Group and Computacenter.

Read more »

Investing Articles

Events I think that could send AstraZeneca shares rallying in 2021

| Jay Yao

Given the start of 2021, Jay Yao writes what he thinks are events that could send AstraZeneca shares potentially higher…

Read more »

Investing Articles

My 2 best shares for 2021

| Karl Loomes

As the New Year starts, now is the perfect time to look for investments that should do well this year.…

Read more »